1.B and T-cell abnormalities in patients with glomerulonephritis.
Chong Myung KANG ; Myung Ju AHN ; Kyoung Won KAHNG
Korean Journal of Nephrology 1993;12(3):304-315
No abstract available.
Glomerulonephritis*
;
Humans
;
T-Lymphocytes*
2.A Case of Mayer-Rokitansky-Kster-Hayser Syndrom.
Kyoung Suk LEE ; Jeong Bae KANG ; Hong Bai KIM ; Keun Yong LEE ; Sung Won KANG
Korean Journal of Obstetrics and Gynecology 1997;40(8):1751-1755
A perplexing developmental error is 46,XX congenital absence of vagina ( Mayer-Rokitan-sky-Kster-Hauser syndrome, Mullerian dysgenesis, vaginal aplasia ). The Mayer-Rokitansky-Kster-Hauser syndrome refers to the climical entity consisting of primary amenorrhea associated with congenital absence of the vagina, 46,XX karyototype, a rudimentary uterus or complete absense, normal overian function and normal ovulation, normal female breast development, body proprotion and body hair, frequent association of renal, skeletal and other cpngenital anomalies. This syndrome results from agenesis of both Mllerian ducts or from a failure of the Mllerian ducts to estavlish a proper communication with that part of the vagina from the urogenital sinus. A case of mayer-Rokitansky-Kster-Hauser syndrom was reviewed briefly.
Amenorrhea
;
Breast
;
Female
;
Hair
;
Humans
;
Ovulation
;
Uterus
;
Vagina
3.Expression of NMDA Receptor Subunit mRNAs in the Developing Circadian Pacemaker of the Rat.
Hwan Tae PARK ; Seung Gu KANG ; Eun Kyoung KANG ; Ki Won BAE
Korean Journal of Anatomy 1998;31(4):595-601
Hypothalamic suprachiasmatic nucleus (SCN) is a circadian pacemaker which controls diurnal behavioral and hormonal rhythms in mammals. The SCN receives environmental light signals through the retinohypothalamic tract, and glutamate is the major excitatory neurotransmitter in the retinohypothalamic tract. In the present study, we investigated the developmental expression of the mRNAs for N-methyl-D-aspartate type glutamate receptor (NR)1, NR2A, NR2B and NR2C subunits in the rat SCN using in situ hybridization with specific riboprobes. At postnatal day 2 (P2), P8, Pl5 and P45, the high level of NRI transcripts was observed in both ventrolateral and dorsomedial subdivisions of the SCN, and the distinct expression of NR2C mRNA was principally found in the dorsomedial SCN. The weak NR2B mRNA expression was clearly found in both subdivisions of the SCN at P2 and P8, whereas specific NR2B hybridization signals were not found at Pl5 and P45. There was no specific hybridization signal of NR2A in the SCN throughout the postnatal life. These findings implicate that NR may play an important role in the neonatal SCN. In addition, this study suggests that NR1, NR2B and NR2C might be the major NR subunits in the developing SCN, whereas NRI and NR2C could be the subunit components of NR in the adult SCN.
Adult
;
Animals
;
Glutamic Acid
;
Humans
;
In Situ Hybridization
;
Mammals
;
N-Methylaspartate*
;
Neurotransmitter Agents
;
Rats*
;
Receptors, Glutamate
;
RNA, Messenger*
;
Suprachiasmatic Nucleus
4.Study of Cytomegalovirus Infection in Renal Transplant Recipients Who had IgG CMV Antibody in the Pretransplantation Period.
Kyoung Won KAHNG ; Chong Myung KANG
Korean Journal of Nephrology 1997;16(1):123-135
Cytomegalovirus(CMV) infection occurs more frequently in renal transplant recipients than in the normal population. But the incidence and severity of CMV infection and antibody positivity are different between countries. We studied the incidence of CMV infection with a long term follow up in renal transplant recipients who were IgG CMV positive and whose donors were also IgG CMV positive preoperatively. We studied the difference and usefulness of various detection methods including IgM CMV antibody by ELISA, shell vial culture, and quantitative dual polymerase chain reaction(PCR). We also studied possible factors that may affect CMV infection and the function of the grafted kidney in CMV infected patients. This study included 36 patients, 20 males and 16 females, who received renal transplantation at Hanyang University Hospital between July, 1994 and March, 1995. IgG and IgM CMV antibodies were detected and shell vial cultures were performed in recipient candidates and donor candidates preoperatively. Postoperatively, we checked IgM CMV and performed shell vial cultures in renal transplant recipients every month after the operation and when CMV infections were suspected. We also performed dual PCR with endpoint titration to quantify the amount of CMV DNA. The total incidence of CMV infection was 30.6% (11 patients among 36 patients). Three patients had CMV disease, and only one patient was severe enough to need gancyclovir therapy. The average onset of infection was 12.9 weeks after the operation(earliest 5weeks-latest 33weeks). In all patients with CMV disease, CMV positivity appeared by all three detection methods. But detection time and duration of positivity were different. The amount of CMV DNA in patients with active CMV disease was higher than those of asymptomatic patients and one patient following antiviral therapy. Age, sex, donor type, HLA matching and rejection did not affect CMV infection. Incidence of CMV infection was higher in patients who were transfused within 3 weeks before the operation(6/8 vs 5/28, p=0.048). Changes of creatinine level from initial outpatient department(OPD) visit to last OPD visit which were corrected by OPD follow up time showed no significant difference between CMV infected and non-infected patients In conclusion, the incidence of CMV infection and disease was relatively low, and the degree of disease severity was mild. In our renal transplant recipients, CMV infection may not be a serious problem. Quantitative dual PCR using end-point titration is a good method to detect CMV infections and monitor the clinical course. Because it is easy to use, detect disease earlier and can quantify the amount of CMV DNA. Among various factors, transfusion affected CMV infection significantly in our patients. In an average of 231 days of OPD follow up time, CMV infected patients showed no impairment of grafted kidney function, but a more long term follow up is needed.
Antibodies
;
Creatinine
;
Cytomegalovirus Infections*
;
Cytomegalovirus*
;
DNA
;
Enzyme-Linked Immunosorbent Assay
;
Female
;
Follow-Up Studies
;
Ganciclovir
;
Humans
;
Immunoglobulin G*
;
Immunoglobulin M
;
Incidence
;
Kidney
;
Kidney Transplantation
;
Male
;
Outpatients
;
Polymerase Chain Reaction
;
Tissue Donors
;
Transplantation*
;
Transplants
5.Three Cases of Renal Tuberculosis in children.
Young Hwa JOUNG ; Kyoung Soo KIM ; Sung Won KANG ; Kyu Hong CHO ; Byung Churl LEE
Journal of the Korean Pediatric Society 1985;28(9):916-921
No abstract available.
Child*
;
Humans
;
Tuberculosis, Renal*
6.Povidone-Iodine related Chemical Burn under the Tourniquet (A Case Report).
Journal of Korean Foot and Ankle Society 2012;16(3):190-192
In the extremity surgery, pneumatic tourniquet and povidone-iodine solution are commonly used to provide an aseptic, bloodless field, and their complication rate has remained low. However, chemical burn under tourniquet has been rarely reported. Patients sustained burn injuries over the dependent, weight-bearing regions such as posterior neck, back, buttocks and posterior thighs. This rare adverse complication occurred in a 22-year-old man who underwent modified Brostrom operation with arthroscopic os trigonum excision. 10% povidone-iodine was used as topical antiseptic, and full thickness burn occurred underneath the area of tourniquet application. Main causes of povidone-iodine related chemical burn are considered maceration, irritation of the skin, long term use of the tourniquet and pressure. To reduce the complications like chemical burn, awareness of the risk and the possible pathogenesis as well as the preventive measures is important in surgical practice.
Burns
;
Burns, Chemical
;
Buttocks
;
Extremities
;
Humans
;
Neck
;
Povidone-Iodine
;
Skin
;
Talus
;
Thigh
;
Tourniquets
;
Weight-Bearing
;
Young Adult
7.Evaluation of the ability of continuous palonosetron infusion, using a patient-controlled analgesia device, to reduce postoperative nausea and vomiting.
Korean Journal of Anesthesiology 2014;67(2):110-114
BACKGROUND: The efficacy of palonosetron in preventing postoperative nausea and vomiting (PONV), as well as chemotherapy-induced nausea and vomiting, has already been demonstrated in multiple clinical studies. The purpose of this study was to determine whether continuous infusion of palonosetron following single injection could reduce PONV to a greater extent than single injection only of palonosetron. METHODS: In total, 132 women were enrolled in the study. All subjects were over the age of 20 years and were scheduled to undergo gynecologic laparoscopic surgery. Patients were randomly allocated into two groups. In both groups, patients received 0.075 mg of palonosetron intravenously, immediately before induction of anesthesia. In the continuous palonosetron infusion group, 0.075 mg (1.5 ml) of palonosetron was added to the patient-controlled analgesia device. In the single-injection palonosetron group, 1.5 ml of normal saline was added. RESULTS: The incidence of PONV 24 hours postoperatively was significantly lower in the continuous palonosetron infusion group than the single-injection palonosetron group (31.8 vs. 56.1%, P = 0.009). CONCLUSIONS: Continuous palonosetron infusion, following single injection, reduces the incidence of PONV compared with single injection only.
Analgesia, Patient-Controlled*
;
Anesthesia
;
Female
;
Humans
;
Incidence
;
Laparoscopy
;
Nausea
;
Postoperative Nausea and Vomiting*
;
Vomiting
8.A case of salmonella peritonitis during continuous ambulatoryperitoneal dialysis.
You Kyoung LEE ; Tae Youn CHOI ; Won Bae KIM ; Duk Yong KANG ; Jun Hee WOO
Korean Journal of Clinical Pathology 1992;12(3):375-379
No abstract available.
Dialysis*
;
Peritonitis*
;
Salmonella*
9.A case of salmonella peritonitis during continuous ambulatoryperitoneal dialysis.
You Kyoung LEE ; Tae Youn CHOI ; Won Bae KIM ; Duk Yong KANG ; Jun Hee WOO
Korean Journal of Clinical Pathology 1992;12(3):375-379
No abstract available.
Dialysis*
;
Peritonitis*
;
Salmonella*